Integral Derivatives’s Baxter International BAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-40,300
Closed -$1.79M 1159
2016
Q4
$1.79M Hold
40,300
0.03% 347
2016
Q3
$1.92M Sell
40,300
-5,000
-11% -$236K 0.04% 275
2016
Q2
$2.05M Buy
45,300
+5,100
+13% +$224K 0.05% 233
2016
Q1
$1.65M Sell
40,200
-15,000
-27% -$572K 0.05% 257
2015
Q4
$2.11M Hold
55,200
0.05% 266
2015
Q3
$1.81M Sell
55,200
-18,440
-25% -$698K 0.05% 336
2015
Q2
$2.8M Buy
+73,640
New +$2.75M 0.08% 233
2015
Q1
Sell
-20,251
Closed -$806K 1092
2014
Q4
$806K Buy
20,251
+10,125
+100% +$394K 0.01% 747
2014
Q3
$395K Hold
10,126
0.01% 1037
2014
Q2
$398K Buy
+10,126
New +$405K 0.01% 1002

Other funds holding BAX

Integral Derivatives's BAX Position: Q4 2016 in Review

Integral Derivatives sold out of Baxter International (BAX) in Q4 2016, closing a stake of 9,982 shares — an estimated $462K sold.

Integral Derivatives first reported a position in BAX in Q2 2014 and held it in 8 quarters. The position peaked at $2.1M in Q2 2015. 921 funds tracked by Wall St. Rank hold BAX as of Q4 2016.

  • Integral Derivatives reported no remaining Baxter International position as of Q4 2016 after selling out during the quarter.
  • Integral Derivatives sold 9,982 Baxter International shares in Q4 2016, an estimated $462K.
  • Integral Derivatives first reported a position in Baxter International in Q2 2014 and held it in 8 quarters.
  • Integral Derivatives's Baxter International position peaked at $2.1M in Q2 2015.
  • 921 funds tracked by Wall St. Rank held Baxter International as of Q4 2016.

Based on Integral Derivatives's 13F filing for Q4 2016, filed 14 Feb 2017.